International Symposium “Clinical Trials in a Globalised Society -Building an Effective Cancer Clinical Trials System-“
date : 5/25/2010
A symposium was held at the British Embassy in Tokyo on May 25, 2010, on the theme of “Clinical Trials in a Globalised Society: Building an Effective System for Cancer Clinical Trials.” The symposium was co-hosted by the Institute in cooperation with the British, American, and Korean Embassies.
Together with visiting experts from each country, over one hundred participants joined in active discussions on how each country is creating effective systems for the cancer domain and development of new medicines in the midst of the ongoing international standardization of clinical research and clinical trial systems.
In the Opening Address, British Ambassador David Warren, U.S. Ambassador John V. Roos, Republic of Korea Minister of Economic Affairs Soon-Taik Hwang, and Japan Cancer Society Goodwill Ambassador Dr. Agnes Chan, together with Institute chairman, Dr. Kiyoshi Kurokawa, greeted participants and stressed the importance of cooperation among the countries in order to deliver effective new medicines more quickly and safely.
During the following Plenary Session, each country’s clinical trial system was introduced by, respectively, Dr. Yung-Jue Bang, Vice President of Korea National Enterprise for Clinical Trials (KoNECT), Dr. Edward Trimble, Head of Gynecologic Cancer Therapeutics and Quality of Cancer Care Therapeutics, Clinical Investigations Branch, at the National Cancer Institute, and Professor Jonathan Ledermann of University College London Cancer Institute. Also, Dr. Toshio Miyata, Assistant Director of Research & Development in the Health Policy Bureau at the Ministry of Health, Labour and Welfare spoke on the current situation and future direction in Japan.
Two panel discussions then followed, exploring the themes of “Promoting International Collaboration in Cancer Clinical Trials” and “Collaboration with Patient Groups”, with active debate on how best to attain a system enabling patient-centered clinical trials while also promoting international collaboration.
To conclude the symposium, concrete ideas and proposals for the future were generated through a review of the day’s discussions and comments from participants. Mr. Kan Suzuki, Senior Vice Minister of Education, Culture, Sports, Science and Technology, then closed the event with a speech emphasizing the importance of clinical research and trials as part of the policy of “Life Innovation,” one of the administration’s growth strategies centered on the healthcare field.
With the continued need for both the improvement and globalization of the clinical research and trial systems, it is anticipated that the four countries will collaborate further in sharing best practices and investigating future issues. It is hoped, therefore, that this symposium can serve as a foundation for deepening discussion and common policy implementation.
Together with visiting experts from each country, over one hundred participants joined in active discussions on how each country is creating effective systems for the cancer domain and development of new medicines in the midst of the ongoing international standardization of clinical research and clinical trial systems.
In the Opening Address, British Ambassador David Warren, U.S. Ambassador John V. Roos, Republic of Korea Minister of Economic Affairs Soon-Taik Hwang, and Japan Cancer Society Goodwill Ambassador Dr. Agnes Chan, together with Institute chairman, Dr. Kiyoshi Kurokawa, greeted participants and stressed the importance of cooperation among the countries in order to deliver effective new medicines more quickly and safely.
During the following Plenary Session, each country’s clinical trial system was introduced by, respectively, Dr. Yung-Jue Bang, Vice President of Korea National Enterprise for Clinical Trials (KoNECT), Dr. Edward Trimble, Head of Gynecologic Cancer Therapeutics and Quality of Cancer Care Therapeutics, Clinical Investigations Branch, at the National Cancer Institute, and Professor Jonathan Ledermann of University College London Cancer Institute. Also, Dr. Toshio Miyata, Assistant Director of Research & Development in the Health Policy Bureau at the Ministry of Health, Labour and Welfare spoke on the current situation and future direction in Japan.
Two panel discussions then followed, exploring the themes of “Promoting International Collaboration in Cancer Clinical Trials” and “Collaboration with Patient Groups”, with active debate on how best to attain a system enabling patient-centered clinical trials while also promoting international collaboration.
To conclude the symposium, concrete ideas and proposals for the future were generated through a review of the day’s discussions and comments from participants. Mr. Kan Suzuki, Senior Vice Minister of Education, Culture, Sports, Science and Technology, then closed the event with a speech emphasizing the importance of clinical research and trials as part of the policy of “Life Innovation,” one of the administration’s growth strategies centered on the healthcare field.
With the continued need for both the improvement and globalization of the clinical research and trial systems, it is anticipated that the four countries will collaborate further in sharing best practices and investigating future issues. It is hoped, therefore, that this symposium can serve as a foundation for deepening discussion and common policy implementation.
Exhibition date：2010-05-25
Top Research & Recommendations Posts
- [Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] AMR Policy Update #4: Cancer Care and AMR (Part 1)
- [Public Comment Submission] “Assessment Report on Climate Change Impacts in Japan (Draft Overview)” (December 24, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
Featured Posts
-
2026-01-09
[Registration Open] (Hybrid Format) Dementia Project FY2025 Initiative Concluding Symposium “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (March 9, 2026)
![[Registration Open] (Hybrid Format) Dementia Project FY2025 Initiative Concluding Symposium “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (March 9, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/dementia-20260309-top.png)
-
2026-02-05
[Registration Open] (Webinar) The 141st HGPI Seminar “Current Status and Future Prospects of Korea’s Obesity Policy: Voices of People with Lived Experience in Policy Promotion” (March 3, 2026)
![[Registration Open] (Webinar) The 141st HGPI Seminar “Current Status and Future Prospects of Korea’s Obesity Policy: Voices of People with Lived Experience in Policy Promotion” (March 3, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/hs141-top-1.png)
